Table 2 Aim 2 evaluation
| Â | Measures description | Instrument/data source | Timing |
|---|---|---|---|
Primary outcome | Carbon monoxide-confirmed abstinence | Follow-up patient visit | 6Â months |
Other cessation outcomes | Continuous abstinence, quit attempts, smoking reduction | Phone assessment | 1, 3, 6Â months |
Patient-level mediators | Risk perceptions, self-efficacy, social norms | Phone assessment | 0, 1, 3, 6Â months |
Provider-level mediator | Provider behavior, delivery of AAA, AAC | Patient survey | Index visit |
Patient-level moderators | Age, sex, education, cigarettes/waterpipes per day, nicotine dependence, prior quit attempts | Patient survey | Index visit |
Clinic- and provider-level moderators | Clinic characteristics (priority, climate), provider knowledge, attitudes, self-efficacy | Provider interview/survey | Pre-trial |
Cost | Intervention delivery costs | Cost survey/electronic log | Trial |